LONG-TERM EFFICACY AND SAFETY OF THE ORAL PYRUVATE KINASE ACTIVATOR MITAPIVAT IN ADULTS WITH NON–TRANSFUSION-DEPENDENT ALPHA- OR BETA-THALASSEMIA
KH Kuoa, DM Laytonb, A Lalc, H Al-Samkarid, J Bhatiae, PA Kosinskie, B Tonge, M Lynche, K Uhlige, EP Vichinskyc
a Division of Hematology, University of Toronto, Toronto, Canada
b Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, United Kingdom
c Division of Hematology, UCSF Benioff Children's Hospital Oakland, Oakland, United States
d Massachusetts General Hospital, Harvard Medical School, Boston, United States
e Agios Pharmaceuticals, Inc., Cambridge, United States
Read
1902
Timeswas read the article
887
Total PDF
1015
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 9 | 70 | 152 | 222 |
| 2025 8 | 48 | 45 | 93 |
| 2025 7 | 51 | 23 | 74 |
| 2025 6 | 41 | 19 | 60 |
| 2025 5 | 50 | 12 | 62 |
| 2025 4 | 34 | 17 | 51 |
| 2025 3 | 53 | 22 | 75 |
| 2025 2 | 38 | 16 | 54 |
| 2025 1 | 36 | 25 | 61 |
| 2024 12 | 33 | 22 | 55 |
| 2024 11 | 42 | 20 | 62 |
| 2024 10 | 31 | 20 | 51 |
| 2024 9 | 45 | 19 | 64 |
| 2024 8 | 36 | 25 | 61 |
| 2024 7 | 36 | 27 | 63 |
| 2024 6 | 35 | 24 | 59 |
| 2024 5 | 52 | 24 | 76 |
| 2024 4 | 31 | 21 | 52 |
| 2024 3 | 21 | 20 | 41 |
| 2024 2 | 16 | 30 | 46 |
| 2024 1 | 19 | 18 | 37 |
| 2023 12 | 14 | 19 | 33 |
| 2023 11 | 20 | 32 | 52 |
| 2023 10 | 13 | 31 | 44 |
| 2023 9 | 14 | 27 | 41 |
| 2023 8 | 15 | 23 | 38 |
| 2023 7 | 17 | 10 | 27 |
| 2023 6 | 20 | 20 | 40 |
| 2023 5 | 13 | 14 | 27 |
| 2023 4 | 10 | 12 | 22 |
| 2023 3 | 9 | 16 | 25 |
| 2023 2 | 9 | 15 | 24 |
| 2023 1 | 11 | 10 | 21 |
| 2022 12 | 17 | 24 | 41 |
| 2022 11 | 11 | 23 | 34 |
| 2022 10 | 4 | 10 | 14 |
Show all
